Cargando…
Emergence of SARS-CoV-2 resistance mutations in a patient who received anti-SARS-COV2 spike protein monoclonal antibodies: a case report
BACKGROUND: To manage severe or potentially severe cases of CoronaVirus Disease 2019 (COVID-19), therapeutic monoclonal antibodies targeting Spike protein of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been designed. It has been noted in vitro that upon exposure to these treatm...
Autores principales: | Fenaux, Honorine, Gueneau, Romain, Chaghouri, Amal, Henry, Benoît, Mouna, Lina, Roque-Afonso, Anne-Marie, Vauloup-Fellous, Christelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649676/ https://www.ncbi.nlm.nih.gov/pubmed/34876033 http://dx.doi.org/10.1186/s12879-021-06902-1 |
Ejemplares similares
-
Validation of a SARS-CoV-2 Surrogate Virus Neutralization Test in Recovered and Vaccinated Healthcare Workers
por: Mouna, Lina, et al.
Publicado: (2023) -
Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test
por: Dortet, Laurent, et al.
Publicado: (2020) -
Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs
por: Lambert-Niclot, Sidonie, et al.
Publicado: (2020) -
Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2
por: Egloff, Charles, et al.
Publicado: (2020) -
Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients
por: Lamy, Gaspard, et al.
Publicado: (2021)